FIRST APPLICATION OF MINIMAL RESIDUAL DISEASE ANALYSIS IN SPLENIC MARGINAL ZONE LYMPHOMA TRIALS: PRELIMINARY RESULTS FROM BRISMA/IELSG36 PHASE II STUDY. (12th June 2019)

• Record Type: Journal Article
• Authors: Ferrero, S.; Ladetto, M.; Beldjord, K.; Drandi, D.; Stelitano, C.; Bernard, S.; Castagnari, B.; Bouabdallah, K.; Cesaretti, M.; Alvarez, I.; Gressin, R.; Ponzoni, M.; Tripodo, C.; Traverse‐Glehen, A.; Baseggio, L.; Liberati, A.; Merli, M.; Tessoulin, B.; Patti, C.; Cabras, M.; Feugier, P.; Pozzi, S.; Zucca, E.; Iannitto, E.; Thieblemont, C.
• Is Part Of: Hematological oncology. Volume 37(2019)Supplement 2
• Page Start: 224
• Page End: 225
• Publication Date: 2019-06-12
• Subjects: Hematological oncology -- Periodicals; Hematology; Medical Oncology; 616.99418005
• DOI: 10.1002/hon.39_2630
• Languages: English
• ISSNs: 0278-0232